No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Fluorescence
-
Genotype
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Inosine Triphosphatase
-
Point Mutation
-
Polymerase Chain Reaction / methods
-
Polymorphism, Genetic
-
Predictive Value of Tests
-
Purines / adverse effects
-
Pyrophosphatases / blood
-
Pyrophosphatases / genetics*
-
RNA Splicing
-
Risk Assessment
Substances
-
Antineoplastic Agents
-
Immunosuppressive Agents
-
Purines
-
Pyrophosphatases